JOINT CORP/THE (JYNT) Stock Fundamental Analysis
NASDAQ:JYNT - Nasdaq - US47973J1025 - Common Stock - Currency: USD
Overall JYNT gets a fundamental rating of 4 out of 10. We evaluated JYNT against 108 industry peers in the Health Care Providers & Services industry. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability. JYNT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year JYNT has reported negative net income.
JYNT had a positive operating cash flow in the past year.
Of the past 5 years JYNT 4 years were profitable.
Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
JYNT has a Return On Assets of -21.18%. This is amonst the worse of the industry: JYNT underperforms 80.37% of its industry peers.
Looking at the Return On Equity, with a value of -82.42%, JYNT is doing worse than 76.64% of the companies in the same industry.
With a Return On Invested Capital value of 2.64%, JYNT perfoms like the industry average, outperforming 46.73% of the companies in the same industry.
JYNT had an Average Return On Invested Capital over the past 3 years of 3.17%. This is below the industry average of 8.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.18% | ||
| ROE | -82.42% | ||
| ROIC | 2.64% |
ROA(3y)-0.61%
ROA(5y)5.15%
ROE(3y)-4.16%
ROE(5y)21.54%
ROIC(3y)3.17%
ROIC(5y)5.54%
1.3 Margins
With a Operating Margin value of 1.14%, JYNT perfoms like the industry average, outperforming 43.93% of the companies in the same industry.
JYNT's Operating Margin has declined in the last couple of years.
JYNT's Gross Margin of 90.70% is amongst the best of the industry. JYNT outperforms 98.13% of its industry peers.
JYNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.14% | ||
| PM (TTM) | N/A | ||
| GM | 90.7% |
OM growth 3Y-62.75%
OM growth 5Y-26.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JYNT is destroying value.
Compared to 1 year ago, JYNT has more shares outstanding
Compared to 5 years ago, JYNT has more shares outstanding
The debt/assets ratio for JYNT is higher compared to a year ago.
2.2 Solvency
JYNT has an Altman-Z score of 3.07. This indicates that JYNT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of JYNT (3.07) is better than 69.16% of its industry peers.
The Debt to FCF ratio of JYNT is 0.01, which is an excellent value as it means it would take JYNT, only 0.01 years of fcf income to pay off all of its debts.
JYNT's Debt to FCF ratio of 0.01 is amongst the best of the industry. JYNT outperforms 92.52% of its industry peers.
JYNT has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, JYNT belongs to the top of the industry, outperforming 85.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 3.07 |
ROIC/WACC0.29
WACC9.03%
2.3 Liquidity
A Current Ratio of 1.44 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT has a Current ratio (1.44) which is in line with its industry peers.
A Quick Ratio of 1.44 indicates that JYNT should not have too much problems paying its short term obligations.
The Quick ratio of JYNT (1.44) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
The earnings per share for JYNT have decreased strongly by -892.31% in the last year.
Looking at the last year, JYNT shows a small growth in Revenue. The Revenue has grown by 5.75% in the last year.
JYNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.25% yearly.
EPS 1Y (TTM)-892.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y26.1%
Revenue growth 5Y26.25%
Sales Q2Q%2.46%
3.2 Future
JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.05% yearly.
JYNT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.16% yearly.
EPS Next Y42.2%
EPS Next 2Y56.86%
EPS Next 3Y43.05%
EPS Next 5YN/A
Revenue Next Year2.57%
Revenue Next 2Y-5.56%
Revenue Next 3Y-9.16%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 37.34, which means the current valuation is very expensive for JYNT.
JYNT's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.68. JYNT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 37.34 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as JYNT.
JYNT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. JYNT is cheaper than 69.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.75 | ||
| EV/EBITDA | 20.63 |
4.3 Compensation for Growth
JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as JYNT's earnings are expected to grow with 43.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.86%
EPS Next 3Y43.05%
5. Dividend
5.1 Amount
JYNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
11.35
-0.01 (-0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners75.82%
Inst Owner Change-90.29%
Ins Owners1.14%
Ins Owner Change2.02%
Market Cap170.02M
Analysts78.18
Price Target16.7 (47.14%)
Short Float %2.96%
Short Ratio10.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1644.77%
Min EPS beat(2)-2673.53%
Max EPS beat(2)-616.02%
EPS beat(4)1
Avg EPS beat(4)-2109.15%
Min EPS beat(4)-6227.45%
Max EPS beat(4)1080.39%
EPS beat(8)2
Avg EPS beat(8)-812.96%
EPS beat(12)3
Avg EPS beat(12)-559.07%
EPS beat(16)7
Avg EPS beat(16)-354.13%
Revenue beat(2)2
Avg Revenue beat(2)2.63%
Min Revenue beat(2)0.92%
Max Revenue beat(2)4.33%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)4.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.15%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)9
Avg Revenue beat(16)0.58%
PT rev (1m)0%
PT rev (3m)-1.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-64.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-196.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 37.34 | ||
| P/S | 1.41 | ||
| P/FCF | 25.75 | ||
| P/OCF | 19.6 | ||
| P/B | 8.31 | ||
| P/tB | 10.49 | ||
| EV/EBITDA | 20.63 |
EPS(TTM)-1.03
EYN/A
EPS(NY)0.3
Fwd EY2.68%
FCF(TTM)0.44
FCFY3.88%
OCF(TTM)0.58
OCFY5.1%
SpS8.06
BVpS1.37
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.18% | ||
| ROE | -82.42% | ||
| ROCE | 3.34% | ||
| ROIC | 2.64% | ||
| ROICexc | 5.3% | ||
| ROICexgc | 6.67% | ||
| OM | 1.14% | ||
| PM (TTM) | N/A | ||
| GM | 90.7% | ||
| FCFM | 5.47% |
ROA(3y)-0.61%
ROA(5y)5.15%
ROE(3y)-4.16%
ROE(5y)21.54%
ROIC(3y)3.17%
ROIC(5y)5.54%
ROICexc(3y)4.42%
ROICexc(5y)8.38%
ROICexgc(3y)5.83%
ROICexgc(5y)11.77%
ROCE(3y)4.02%
ROCE(5y)7.01%
ROICexcg growth 3Y-55.68%
ROICexcg growth 5YN/A
ROICexc growth 3Y-57.16%
ROICexc growth 5Y-38.54%
OM growth 3Y-62.75%
OM growth 5Y-26.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5Y0.62%
F-Score5
Asset Turnover1.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 35.34% | ||
| Cap/Sales | 1.71% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 119.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 3.07 |
F-Score5
WACC9.03%
ROIC/WACC0.29
Cap/Depr(3y)108.43%
Cap/Depr(5y)124.84%
Cap/Sales(3y)6.27%
Cap/Sales(5y)6.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-892.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
EPS Next Y42.2%
EPS Next 2Y56.86%
EPS Next 3Y43.05%
EPS Next 5YN/A
Revenue 1Y (TTM)5.75%
Revenue growth 3Y26.1%
Revenue growth 5Y26.25%
Sales Q2Q%2.46%
Revenue Next Year2.57%
Revenue Next 2Y-5.56%
Revenue Next 3Y-9.16%
Revenue Next 5YN/A
EBIT growth 1Y288.98%
EBIT growth 3Y-53.03%
EBIT growth 5Y-6.9%
EBIT Next Year672.03%
EBIT Next 3Y125.51%
EBIT Next 5YN/A
FCF growth 1Y537.22%
FCF growth 3Y6.47%
FCF growth 5Y17.4%
OCF growth 1Y96.21%
OCF growth 3Y9.5%
OCF growth 5Y21.91%